Skip to main content

Table 2 Factor and their loadings derived by 25 acylcarnitine metabolites

From: The association and prediction value of acylcarnitine on diabetic nephropathy in Chinese patients with type 2 diabetes mellitus

Variables

Factor1

Factor2

Factor3

Factor4

Factor5

Factor6

C2

0.50429

0.34748

0.14162

0.68981

0.10081

-0.02151

C3

0.08067

0.53851

0.21331

0.19845

0.45228

-0.09907

C4

0.59019

0.251

0.03502

0.53335

0.33466

-0.08973

C4-OH

0.07685

0.00693

0.07368

0.82499

0.00633

0.24523

C4DC

0.15497

0.01182

0.36127

-0.08586

0.55835

-0.07317

C5

0.25588

0.22914

0.10886

0.48798

0.5693

0.03655

C5-OH

0.02242

0.14218

0.1133

-0.01669

0.70797

0.33312

C5DC

0.79163

0.07983

0.16201

0.30658

0.05912

0.00873

C5:1

0.31919

0.17655

-0.00946

0.29204

0.48242

0.11599

C6

0.8317

0.16068

0.05042

0.30218

0.13862

0.02847

C8

0.93584

0.10313

0.05502

0.0886

0.08998

0.01758

C10

0.89856

0.09134

0.06551

-0.0812

0.09491

0.13032

C12

0.73262

0.20815

-0.01328

-0.09524

0.15774

0.44017

C14

0.43019

0.46226

-0.10485

0.00559

0.21252

0.51255

C14-OH

0.45857

0.09468

0.05866

0.18343

0.10609

0.46761

C14DC

0.40245

0.28539

0.55178

0.33555

0.00955

-0.047

C14:1

0.80376

0.19505

0.11113

0.11034

0.07487

0.14416

C16

0.2405

0.83777

0.06037

0.06701

0.13985

0.1017

C16-OH

0.08469

0.2005

0.18094

0.15398

0.07779

0.69627

C16:1-OH

0.14883

0.68625

0.31955

0.06626

0.08016

0.15477

C18

0.16894

0.83086

0.17011

0.08513

0.14699

0.15219

C20

0.07642

0.48323

0.32206

0.11856

-0.02242

0.16375

C22

-0.01123

0.2058

0.69597

0.32022

0.01519

0.21193

C24

0.09035

0.1236

0.78191

-0.03713

0.18574

0.16162

C26

0.03762

0.23012

0.76184

-0.04315

0.20975

-0.09637

  1. C2, acetylcarnitine; C3, propionylcarnitine; C4, butyrylcarnitine; C4-OH, hydroxylbutyrylcarnitine; C4DC, succinylcarnitine; C5, isovalerylcarnitine; C5-OH, 3-hydroxyisovalerylcarnitine; C5DC, glutarylcarnitine; C5:1, tiglylcarnitine; C6, hexanoylcarnitine; C8, octanoylcarnitine; C10, decanoylcarnitine; C12, lauroylcarnitine; C14, myristoylcarnitine; C14-OH, 3-hydroxyl-tetradecanoylcarnitine; C14DC, tetradecanoyldiacylcarnitine; C14:1, tetradecenoylcarnitine; C16, palmitoylcarnitine; C16-OH, 3-hydroxypalmitoylcarnitine; C16:1-OH, 3-hydroxypalmitoleylcarnitine; C18, octadecanoylcarnitine; C20, arachidic carnitine; C22, behenic carnitine; C24, tetracosanoic carnitine; C26, hexacosanoic carnitine
  2. The factors were extracted from 25 acylcarnitine according to eigenvalue > 1, scree plot, and cumulative variance by principal component analysis. Varimax rotation was used to maximize the variance difference of each factor, so as to better explain the factors. Each black-marked acylcarnitine in each column is classified as a factor in the corresponding column